Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan 18:7:694.
doi: 10.3389/fimmu.2016.00694. eCollection 2016.

STATs in NK-Cells: The Good, the Bad, and the Ugly

Affiliations
Review

STATs in NK-Cells: The Good, the Bad, and the Ugly

Dagmar Gotthardt et al. Front Immunol. .

Abstract

Natural killer (NK)-cells are major players in the fight against viral infections and transformed cells, but there is increasing evidence attributing a disease-promoting role to NK-cells. Cytokines present in the tumor microenvironment shape NK-cell maturation, function, and effector responses. Many cytokines signal via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway that is also frequently altered and constitutively active in a broad range of tumor cells. As a consequence, there are currently major efforts to develop therapeutic strategies to target this pathway. Therefore, it is of utmost importance to understand the role and contributions of JAK-STAT molecules in NK-cell biology-only this knowledge will allow us to predict effects of JAK-STAT inhibition for NK-cell functions and to successfully apply precision medicine. We will review the current knowledge on the role of JAK-STAT signaling for NK-cell functions and discuss conditions involved in the switch from NK-cell tumor surveillance to disease promotion.

Keywords: JAK–STAT; NK cells; VEGF-A; cytotoxicity; immunologic; mouse models; tumor promotion; tumor surveillance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The role of STATs for NK cell homeostasis and function.

Similar articles

Cited by

References

    1. Caligiuri MA. Human natural killer cells. Blood (2008) 112:461–9.10.1182/blood-2007-09-077438 - DOI - PMC - PubMed
    1. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol (2001) 22:633–40.10.1016/S1471-4906(01)02060-9 - DOI - PubMed
    1. Waldhauer I, Steinle A. NK-cells and cancer immunosurveillance. Oncogene (2008) 27:5932–43.10.1038/onc.2008.267 - DOI - PubMed
    1. Vermijlen D, Luo D, Froelich CJ, Medema JP, Kummer JA, Willems E, et al. Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway. J Leukoc Biol (2002) 72:668–76. - PubMed
    1. Giezeman-Smits KM, Gorter A, van Vlierberghe RL, Giezeman-Smits KM, v Eendenburg JD, Eggermont AM, et al. The regulatory role of CD45 on rat NK-cells in target cell lysis. J Immunol Ref J Immunol UCSF Libr (2016) 163:71–6. - PubMed